Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bischoff

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|July 16, 2010
[First symposium of the Bavarian LARE (Statewide Working Group on Multiresistant Pathogens)]U Kandler, H Bischoff, K Finger, et al.
American Journal of Hypertension|June 20, 2001
Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibitionR Dechend, A Fiebler, C Lindschau, et al.
Cancer Treatment Reports|December 1, 1985
Synthesis, toxicity, and therapeutic efficacy of 4-amino-N-(2'-aminophenyl)-benzamide: a new compound preferentially active in slowly growing tumorsM R Berger, H Bischoff, E Fritschi, et al.
Atherosclerosis|December 12, 1997
Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitorH Bischoff, R Angerbauer, J Bender, et al.
Clinical Neurology and Neurosurgery|April 30, 2013
Neurophysiologic, audiometric and vestibular function tests in patients with hyperostosis cranialis internaJ J Waterval, M P H Bischoff, R J Stokroos, et al.
Der Radiologe|September 17, 1998
[Ultrafast MRI phlebography of the lungs]S O Schoenberg, M V Knopp, A Grau, et al.
Proteomics. Clinical Applications|October 5, 2017
Comparison of Targeted Mass Spectrometry Techniques with an Immunoassay: A Case Study for HSP90αCoşkun Güzel, Natalia I Govorukhina, Christoph Stingl, et al.
Structure (London, England : 1993)|March 7, 1998
The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitorS E Zographos, N G Oikonomakos, K E Tsitsanou, et al.
Pulmonology|April 13, 2024
Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation studyS Safi, J Krzykalla, H Hoffmann, et al.
Pneumologie (Stuttgart, Germany)|May 7, 2009
[Palliative care in respiratory medicine]H Magnussen, D F Heigener, C Bausewein, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|July 16, 2010
[First symposium of the Bavarian LARE (Statewide Working Group on Multiresistant Pathogens)]U Kandler, H Bischoff, K Finger, et al.
American Journal of Hypertension|June 20, 2001
Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibitionR Dechend, A Fiebler, C Lindschau, et al.
Cancer Treatment Reports|December 1, 1985
Synthesis, toxicity, and therapeutic efficacy of 4-amino-N-(2'-aminophenyl)-benzamide: a new compound preferentially active in slowly growing tumorsM R Berger, H Bischoff, E Fritschi, et al.
Atherosclerosis|December 12, 1997
Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitorH Bischoff, R Angerbauer, J Bender, et al.
Clinical Neurology and Neurosurgery|April 30, 2013
Neurophysiologic, audiometric and vestibular function tests in patients with hyperostosis cranialis internaJ J Waterval, M P H Bischoff, R J Stokroos, et al.
Der Radiologe|September 17, 1998
[Ultrafast MRI phlebography of the lungs]S O Schoenberg, M V Knopp, A Grau, et al.
Proteomics. Clinical Applications|October 5, 2017
Comparison of Targeted Mass Spectrometry Techniques with an Immunoassay: A Case Study for HSP90αCoşkun Güzel, Natalia I Govorukhina, Christoph Stingl, et al.
Structure (London, England : 1993)|March 7, 1998
The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitorS E Zographos, N G Oikonomakos, K E Tsitsanou, et al.
Pulmonology|April 13, 2024
Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation studyS Safi, J Krzykalla, H Hoffmann, et al.
Pneumologie (Stuttgart, Germany)|May 7, 2009
[Palliative care in respiratory medicine]H Magnussen, D F Heigener, C Bausewein, et al.
Pageof 8